Novo-Nordisk A/S (NVO) is a publicly traded Healthcare sector company. As of July 26, 2026, NVO trades at $48.77 with a market cap of $215.70B and a P/E ratio of 0.00. NVO moved +1.08% today. Year to date, NVO is -4.15%; over the trailing twelve months it is -31.05%. Its 52-week range spans $35.12 to $112.52. Analyst consensus is neutral with an average price target of $44.67. Rallies surfaces NVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for NVO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $48.77 |
| Market Cap | $215.70B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 1.22% |
| 52-Week High | $112.52 |
| 52-Week Low | $35.12 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover NVO: 0 strong buy, 0 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $44.67.